Document:

Exhibit 4.1

 

This
Nonstatutory Stock Option Agreement (“Agreement”) is made and entered into as of the date set forth below,
by and between Ipsidy Inc., a Delaware corporation (the “Company”), and the following Executive of the Company (“Optionee”):

 

In consideration of the covenants
herein set forth, the parties hereto agree as follows:

 

		1.	Option Information.

		(a)	Date of Option:	______, 2021

		(b)	Optionee:	____________

		(c)	Number of Shares:	______________

		(d)	Exercise Price:	$____

		(e)	Expiration Date:	___________, 2031

 

		2.	Acknowledgements.

(a)
Optionee is a Director or employee of the Company.

 

(b) The
Board of Directors (the “Board” which term shall include an authorized committee of the Board of Directors) and shareholders
of the Company have heretofore adopted a 2017 Incentive Stock Plan (the “Plan”) This Option is not being granted subject
to the terms of the Plan but may become subject to the terms of the Plan if so ratified by the stockholders. For the purposes of interpretation
of this Option the provisions of the Plan shall be deemed incorporated herein by reference but in the event of any conflict between the
provisions of the Plan and the provisions of this Option, the provisions of this Option shall prevail; and

 

(c) The
Board has authorized the granting to Optionee of a nonstatutory stock option (“Option”) to purchase shares of common
stock of the Company (“Stock”) upon the terms and conditions hereinafter stated and pursuant to an exemption from registration
under the Securities Act of 1933, as amended (the “Securities Act”) provided by Section 4(2) thereunder.

 

3. Shares;
Price. Company hereby grants to Optionee the right to purchase, upon and subject to the terms and conditions herein stated, the number
of shares of Stock set forth in Section 1(c) above (the “Shares”) for cash (or other consideration as is authorized
under the Plan and acceptable to the Board of Directors of the Company, in their sole and absolute discretion) at the price per Share
set forth in Section 1(d) above (the “Exercise Price”), such price being not less than the fair market value per share
of the Shares covered by this Option as of the date hereof.

 

4. Term
of Option; Continuation of Service. This Option shall expire, and all rights hereunder to purchase the Shares shall terminate, ten
(10) years from the date hereof, as set forth in Section 1(e) above (“Expiration Date”). This Option shall earlier
terminate subject to Sections 7 and 8 hereof upon, and as of the date of, the termination of Optionee’s office or employment if
such termination occurs prior to the Expiration Date. Nothing contained herein shall confer upon Optionee the right to the continuation
of his or her office or employment with the Company or to interfere with the right of the Company to terminate such office or employment
or to increase or decrease the compensation of Optionee from the rate in existence at the date hereof.

 

     

     

    

 

5. Vesting
of Option. Subject to the provisions of Sections 7 and 8 hereof, this Option shall become exercisable and the Shares shall vest during
the term of Optionee’s office or employment as follows:

 

		(a)	_________________ of the Shares shall vest and become exercisable upon satisfaction of the first to occur
of the following conditions:

 

		(i)	A minimum annualized revenue run-rate of the Company and its subsidiaries on a consolidated basis of $_______________,
based on the revenue for any quarterly period, excluding non-recurring one-time payments (as defined below), determined in accordance
with United States Generally Accepted Accounting Principles (“GAAP”) as shown in any of the Company’s Annual
Reports on Form 10-K, or Quarterly Reports on Form 10-Q filed with the SEC (collectively “SEC Filings”) after the date
hereof; or

 

		(ii)	The Company’s Shares achieving a closing price on the principal market or exchange on which such
shares are traded, which gives rise to a Fully Diluted Market Capitalization (as defined below) of the Company of not less than $_______________
for a period of not less than six consecutive months (183 calendar days).

 

		(b)	_____________________ of the Shares shall vest and become exercisable upon satisfaction of the first to
occur of the following conditions:

 

		(i)	A minimum annualized revenue run-rate of the Company and its subsidiaries on a consolidated basis of $____________________,
based on the revenue for any quarterly period, excluding non-recurring one-time payments, determined in accordance with GAAP as shown
in any of the Company’s SEC Filings after the date hereof; or

 

		(ii)	The Company’s Shares achieving a closing price on the principal market or exchange on which such
shares are traded, which gives rise to a Fully Diluted Market Capitalization (as defined below) of the Company of not less than $_______________
for a period of not less than six consecutive months (183 calendar days).

 

		(c)	_________________ of the Shares shall vest and become exercisable upon satisfaction of the first to occur
of the following conditions:

 

		(i)	A minimum annualized revenue run-rate of the Company and its subsidiaries on a consolidated basis of $______________,
based on the revenue for any quarterly period, excluding non-recurring one-time payments, determined in accordance with GAAP as shown
in any of the Company’s SEC Filings after the date hereof; or

 

		(ii)	The Company’s Shares achieving a closing price on the principal market or exchange on which such
shares are traded, which gives rise to a Fully Diluted Market Capitalization (as defined below) of the Company of not less than $___________________
for a period of not less than six consecutive months (183 calendar days).

 

		(d)	___________________ of the Shares shall vest and become exercisable as to _________________ of the Shares
covered by this Option at the end of each month commencing with the month following the date of this Option, over a period of forty-eight
(48) months, subject to Optionee’s continued service to the Company.

 

    2

     

    

 

		(e)	Upon the occurrence of a Change of Control (as defined below), prior to the occurrence of any of the other
vesting conditions, up to 100% of the Shares subject to this Option shall vest to the extent not previously vested.

 

		(f)	“Fully Diluted Market Capitalization” shall mean the amount which results from the following calculations or determinations:

 

		(i)	the closing price of the Shares on the principal market or exchange on which the Company’s Shares
are traded on the relevant date multiplied by

 

		(ii)	the aggregate of the following amounts (1) the number of issued and outstanding Shares of common stock
on the relevant date; and (2) the number of Shares which are issuable pursuant to the exercise of any options of warrants or other instruments
giving the right to call for the issuance of Shares, at an exercise price which is not more than the applicable closing price under sub-section
(i) above; and (3) the number of Shares which are issuable pursuant to the conversion of any convertible note or other instruments giving
the right to convert into Shares, at a conversion price which is not more than the applicable closing price under sub-section (i) above.

 

		(d)	“Change of Control” shall have the meaning set forth in Optionee’s Executive
Retention Agreement, except if any of the events set forth in such Agreement occurs in circumstances of the liquidation of the Company
pursuant to a bankruptcy, or other insolvency proceeding.

 

		(e)	“Non-recurring one-time payments”
shall mean any revenue or accounts receivable derived from (i) sales of inventory, goods, equipment,
or other assets of the Group not in the ordinary course of business, (ii) transaction revenue not received in the ordinary course of business,
(iii) sales of services not in the ordinary course of business, or (iv) revenue received due to one-time, non-recurring transactions.

By
way of example, if in a particular quarter the Company has $3,000,000 of revenue but $1,000,000 results from the sale of a subsidiary,
or its assets, then for the purposes of the revenue condition the Company shall be deemed to have had revenue of $2,000,000 in that quarter
and an annualized revenue run rate of $8,000,000.

 

		(g)	The installments shall be cumulative (i.e., this option may be exercised, as to any or all Shares covered
by an installment, at any time or times after an installment becomes exercisable and until expiration or termination of this Option).
If any vesting condition is not satisfied before the earlier of the expiration or termination date of this Option, or termination of the
Optionee’s service to the Company, the Option shall lapse as to the unvested Shares.

 

		6.	Exercise.

 

(a) Standard
Exercise. This Option shall be exercised by delivery to the Company of (i) written notice of exercise stating the number of Shares
being purchased (in whole shares only) and such other information set forth on the form of Notice of Exercise attached hereto as Appendix
A, (i) a check or cash in the amount of the Exercise Price of the Shares covered by the notice (or such other consideration as has
been approved by the Board of Directors consistent with the Plan) and (iii) a written investment representation as provided for in Section
13 hereof. This Option shall not be assignable or transferable, except by will or by the laws of descent and distribution, and shall be
exercisable only by Optionee during his or her lifetime, except as provided in Section 8 hereof.

 

    3

     

    

 

(b) Cashless
Exercise. Notwithstanding anything to the contrary contained in this Option, this Option may be exercised by presentation and surrender
of this Option to the Company at its principal executive offices with a written notice of the holder’s intention to effect a cashless
exercise, and such other information set forth on the form of Notice of Exercise attached hereto as Appendix A, including a calculation
of the number of shares of Common Stock to be issued upon such exercise in accordance with the terms hereof (a “Cashless Exercise”).
In the event of a Cashless Exercise, in lieu of paying the Exercise Price in cash, the holder shall surrender this Option for that number
of shares of Common Stock determined by multiplying the number of Shares to which it would otherwise be entitled by a fraction, the numerator
of which shall be the difference between the then current Market Price per share of the Common Stock and the Exercise Price, and the denominator
of which shall be the then current Market Price per share of Common Stock. Market Price is defined as the average of the last reported
sale prices on the principal trading market for the Common Stock during the five (5) trading days immediately preceding such exercise
date.

 

7. Termination
of Appointment.

 

(a) If
Optionee shall cease to be a director, employee or contractor of the Company for any reason, whether voluntarily or involuntarily, other
than by his or her death, Optionee (or if the Optionee shall die after such termination, but prior to such exercise date, Optionee’s
personal representative or the person entitled to succeed to the Option) shall have the right at any time within one (1) year following
such termination of office or the remaining term of this Option, whichever is the lesser, to exercise in whole or in part this Option
to the extent, but only to the extent, that this Option was exercisable as of the date of termination of office and had not previously
been exercised; provided, however: (i) if Optionee is permanently disabled (within the meaning of Section 22(e)(3) of the Code) at the
time of termination, the foregoing one (1) year period shall be extended to two (2) years; or (ii) if Optionee is terminated “for
cause” (as defined below) this Option shall automatically terminate as to all Shares covered by this Option not exercised prior
to termination. Unless earlier terminated, all rights under this Option shall terminate in any event on the Expiration Date.

 

(b) If
the term “for cause” is defined in any employment agreement between the Optionee and the Company, then such definition
shall be used. “For Cause” in this Agreement means (i) an intentional act of
fraud, embezzlement, theft or any other material violation of law that occurs during or in the course of Optionee’s employment or
office with Company; (ii) intentional damage to the Company’s assets; (iii) intentional disclosure of Company’s confidential
information contrary to the Company’s policies; (iv) breach of Optionee’s obligations to the Company; (v) intentional engagement
in any competitive activity which would constitute a breach of Optionee’s duty of loyalty or of Optionee’s obligations to
the Company; (vi) intentional breach of any of Company’s policies; (vii) the willful and continued failure to substantially perform
Optionee’s duties for Company (other than as a result of incapacity due to physical or mental illness); or (viii) willful conduct
by Optionee that is demonstrably and materially injurious to the Company, monetarily or otherwise.

 

8. Death
of Optionee. If the Optionee shall die while holding office of the Company, Optionee’s personal representative or the person
entitled to Optionee’s rights hereunder may at any time within two (2) years after the date of Optionee’s death, or during
the remaining term of this Option, whichever is the lesser, exercise this Option and purchase Shares to the extent, but only to the extent,
that Optionee could have exercised this Option as of the date of Optionee’s death; provided, in any case, that this Option may be
so exercised only to the extent that this Option has not previously been exercised by Optionee.

 

    4

     

    

 

9. No
Rights as Shareholder. Optionee shall have no rights as a shareholder with respect to the Shares covered by any installment of this
Option until the effective date of issuance of the Shares following exercise of this Option, and no adjustment will be made for dividends
or other rights for which the record date is prior to the date such stock certificate or certificates are issued except as provided in
Section 10 hereof.

 

10. Recapitalization.
Subject to any required action by the shareholders of the Company, the number of Shares covered by this Option, and the Exercise Price
thereof, shall be proportionately adjusted for any increase or decrease in the number of issued shares resulting from a subdivision or
consolidation of shares or the payment of a stock dividend, or any other increase or decrease in the number of such shares effected without
receipt of consideration by the Company; provided however that the conversion of any convertible securities of the Company shall not be
deemed having been “effected without receipt of consideration by the Company”.

 

11. Reorganization.
The grant of this Option shall not affect in any way the right or power of the Company to make adjustments, reclassifications, reorganizations
or changes in its capital or business structure or to merge, consolidate, dissolve or liquidate or to sell or transfer all or any part
of its business or assets. The provisions of the Plan shall govern the rights of the Optionee in the event of a Reorganization as defined
in the Plan.

 

12. Taxation
upon Exercise of Option. Optionee understands that, upon exercise of this Option, Optionee will recognize income, for Federal and
state income tax purposes, in an amount equal to the amount by which the fair market value of the Shares, determined as of the date of
exercise, exceeds the Exercise Price. The acceptance of the Shares by Optionee shall constitute an agreement by Optionee to report such
income in accordance with then applicable law and to cooperate with Company in establishing the amount of such income and corresponding
deduction to the Company for its income tax purposes. Withholding for federal or state income and employment tax purposes will be made,
if and as required by law, from Optionee’s then current compensation, or, if such current compensation is insufficient to satisfy
withholding tax liability, the Company may require Optionee to make a cash payment to cover such liability as a condition of the exercise
of this Option.

 

13. Modification,
Extension and Renewal of Options. The Board or Committee, as described in the Plan, may modify, extend or renew this Option or accept
the surrender thereof (to the extent not theretofore exercised) and authorize the granting of a new option in substitution therefore (to
the extent not theretofore exercised), subject at all times to the Plan, the Code and all relevant securities statutes and rules. Notwithstanding
the foregoing provisions of this Section 13, no modification shall, without the consent of the Optionee, alter to the Optionee’s
detriment or impair any rights of Optionee hereunder.

 

14. Investment
Intent; Restrictions on Transfer.

 

(a) Optionee
represents and agrees that if Optionee exercises this Option in whole or in part, Optionee will in each case acquire the Shares upon such
exercise for the purpose of investment and not with a view to, or for resale in connection with, any distribution thereof; and that upon
such exercise of this Option in whole or in part, Optionee (or any person or persons entitled to exercise this Option under the provisions
of Sections 7 and 8 hereof) shall furnish to the Company a written statement to such effect, satisfactory to the Company in form and substance.
If the Shares represented by this Option are registered under the Securities Act, either before or after the exercise of this Option in
whole or in part, the Optionee shall be relieved of the foregoing investment representation and agreement and shall not be required to
furnish the Company with the foregoing written statement.

 

(b) Optionee
further represents that Optionee has had access to the published financial statements and other information of the Company, has had the
opportunity to ask questions of the Company concerning its business, operations and financial condition, and to obtain additional information
reasonably necessary to verify the accuracy of such information.

 

    5

     

    

 

(c) Unless
and until the Shares represented by this Option are registered under the Securities Act, all Company records regarding the Shares (which
shall be issued in book entry form) and any securities issued pursuant to any stock split, share reclassification, stock dividend or other
similar capital event shall bear legends in substantially the following form:

 

THESE SECURITIES HAVE NOT
BEEN REGISTERED OR OTHERWISE QUALIFIED UNDER THE SECURITIES ACT OF 1933 (THE ‘SECURITIES ACT’) OR UNDER THE APPLICABLE OR
SECURITIES LAWS OF ANY STATE. NEITHER THESE SECURITIES NOR ANY INTEREST THEREIN MAY BE SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED
OF IN THE ABSENCE OF REGISTRATION UNDER THE SECURITIES ACT OR ANY APPLICABLE SECURITIES LAWS OF ANY STATE, UNLESS PURSUANT TO EXEMPTIONS
THEREFROM.

 

THE SHARES REPRESENTED BY
THIS CERTIFICATE HAVE BEEN ISSUED PURSUANT TO THAT CERTAIN NONSTATUTORY STOCK OPTION AGREEMENT DATED ____________ BETWEEN THE COMPANY
AND THE ISSUEE WHICH RESTRICTS THE TRANSFER OF THESE SHARES WHICH ARE SUBJECT TO REPURCHASE BY THE COMPANY UNDER CERTAIN CONDITIONS.

 

and/or such other legend or legends as the Company
and its counsel deem necessary or appropriate. Appropriate stop transfer instructions with respect to the Shares will be placed with the
Company’s transfer agent.

 

15. Stand-off
Agreement. Optionee agrees that, in connection with any registration of the Company’s securities under the Securities Act, and
upon the request of the Company or any underwriter managing an underwritten offering of the Company’s securities, Optionee shall
not sell, short any sale of, loan, grant an option for, or otherwise dispose of any of the Shares (other than Shares included in the offering)
without the prior written consent of the Company or such managing underwriter, as applicable, for a period of at least six months following
the effective date of registration of such offering.

 

16. Notices.
Any notice required to be given pursuant to this Option or the Plan shall be in writing and shall be deemed to be delivered upon receipt
or, in the case of notices by the Company, five (5) days after deposit in the U.S. mail, postage prepaid, addressed to Optionee at the
address last provided by Optionee for his or her employee/officer records.

 

17. Agreement
Subject to Plan; Applicable Law. This Option is not made pursuant to the Plan, subject to ratification by the stockholders but for
the avoidance of doubt shall be interpreted to comply therewith. A copy of such Plan is available to Optionee, at no charge, at the principal
office of the Company. This Option has been granted, executed and delivered in the State of Delaware, and the interpretation and enforcement
shall be governed by the laws thereof and subject to the exclusive jurisdiction of the courts therein.

 

    6

     

    

 

In
Witness Whereof, the parties hereto have executed this Option as of the date first above written.

 

	COMPANY:	Ipsidy Inc.,
	 	a Delaware corporation
	 	 	 
	 	By:	 
	 	Name:  	 
	 	Title:	 
	 	 	 
	OPTIONEE:	 	 
	 	By:	 
	 		(signature)
	 	Name:	

  

    7

     

    

 

Appendix A

 

NOTICE OF EXERCISE

Ipsidy Inc.

________________

________________

 

Re: Nonstatutory Stock
Option

 

Notice is hereby given pursuant
to Section 6 of my Nonstatutory Stock Option Agreement that I elect to purchase the number of shares set forth below at the exercise price
set forth in my option agreement:

 

Nonstatutory Stock Option
Agreement dated: ____________

 

Number of shares being purchased:
____________

 

Exercise Price: $____________

 

EITHER

 

1) A
check in the amount of the aggregate price of the shares being purchased is attached.

 

OR

 

2) I
elect a cashless exercise pursuant to Section 6 of my Stock Option Agreement. Please determine the Market Price* as of the date of this
Exercise Notice and calculate the resulting number of shares of common stock to be issued on a cashless exercise basis.

 

* Market Price is defined as the average of the
last reported sale prices on the principal trading market for the Common Stock during the five (5) trading days immediately preceding
the exercise date.

 

Further, I understand that
the exercise of the Options will give rise to taxable income at the time of exercise, which will be payable in addition to the Exercise
Price under the Option, whether by deduction from my compensation, or by my additional payment to the Company.

 

I hereby confirm that such
shares are being acquired by me for my own account for investment purposes, and not with a view to, or for resale in connection with,
any distribution thereof. I will not sell or dispose of my Shares in violation of the Securities Act of 1933, as amended, or any applicable
federal or state securities laws.

 

I understand that the Transfer
Agent’s record relating to the Option Shares will bear a restrictive legend within the contemplation of the Securities Act and as
required by such other state or federal law or regulation applicable to the issuance or delivery of the Option Shares.

 

I agree to provide to the
Company such additional documents or information as may be required pursuant to the Company’s 2017 Incentive Stock Plan.

 

	 	By:	 
	 	 
	 	Dated: 	 

 

 

8Exhibit 10.1

 

EXECUTIVE RETENTION AGREEMENT

 

This Executive Retention Agreement
(the “Agreement”) is made and entered into as of June 14, 2021 by and between IPSIDY INC., a Delaware corporation
(the “Company”), and THOMAS THIMOT (the “Executive”).

 

Recitals:

 

WHEREAS, the Executive is
a key employee of the Company who possesses valuable proprietary knowledge of the Company, its business and operations and the markets
in which the Company competes; and

 

WHEREAS, the Company and the
Executive desire to enter into this Agreement to encourage the Executive to continue to devote the Executive’s full attention and
dedication to the success of the Company, and to provide specified compensation and benefits to the Executive in the event of a Termination
Upon Change of Control or certain other terminations pursuant to the terms of this Agreement.

 

NOW, THEREFORE, THE PARTIES HEREBY AGREE AS FOLLOWS:

1.
PURPOSE AND TERM

 

The purpose of this Agreement
is to provide specified compensation and benefits to the Executive in the event of (i) a Termination Upon Change of Control or (ii) an
Involuntary Termination. Subject to the terms of any applicable written employment agreement between Company and the Executive (as to
which Executive acknowledges no other such agreement exists as of the date hereof), either the Executive or Company may terminate the
Executive’s employment at any time for any reason, with or without notice. The term of this Agreement shall be the period from the
date set forth above until Executive’s employment is terminated for any reason or this Agreement is terminated by mutual agreement
of the parties.

 

2.
TERMINATION GENERALLY

 

2.1 Termination
of Employment Generally. In the event the Executive’s employment with the Company terminates, for any reason whatsoever including
death or disability the Executive shall be entitled to the benefits described in this Section 2.1.

 

2.1.1 Accrued
Salary and Vacation. All salary and accrued vacation earned through the Termination Date shall be paid to Executive on such Date.

 

2.1.2 Accrued
Bonus Payment. The Executive shall receive a lump sum payment of any actual bonus amount to the extent that all the conditions for
payment of such bonus have been satisfied and any such bonus was earned and is unpaid on the Termination Date.

 

2.1.3 Expense
Reimbursement. Within ten (10) days following submission to the Company of proper expense reports by the Executive, the Company shall
reimburse the Executive for all expenses incurred by the Executive, consistent with the Company’s expense reimbursement policy in
effect prior to the incurring of each such expense, in connection with the business of the Company prior to the Termination Date.

 

     

     

    

 

3. TERMINATION
UPON CHANGE OF CONTROL

 

3.1 Severance
Payment. In the event of the Executive’s Termination Upon Change of Control, the Executive shall be entitled to receive an amount
equal to twelve (12) months of the Executive’s Base Salary and 100% of Executive’s target annual bonus for the year in which
the Termination Date occurs (or, if greater, the target annual bonus in effect immediately prior to the Change of Control) which shall
be paid in a lump sum payment within ten (10) days following the Termination Date; provided, however, that if Section 409A of the Code
would otherwise apply to such cash severance payment, it instead shall be paid at such time as permitted by Section 409A of the Code.
This section shall not apply and no severance payment shall be payable hereunder to the extent of the amount of any bonus payable to Executive
upon a Change of Control.

 

3.2 COBRA.
The Company will reimburse Executive for the cost of continuation of health coverage for Executive and Executive’s eligible dependents
pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”) until the earlier
of (i) 12 months following the Termination Date, (ii) the date Executive is eligible for health coverage for Executive and Executive’s
eligible dependents from a new employer or (iii) the date Executive and Executive’s eligible dependents are no longer eligible for
COBRA; provided, however, if, at the time of the Termination Date, the Company determines that providing the COBRA reimbursement in this
paragraph would result in a violation of law or an excise tax to the Company, then the Company instead will pay a lump sum payment equal
to 150% of 12 months of Executive’s estimated COBRA premiums, less applicable withholdings, within 10 days following the Termination
Date.

 

3.3 Equity Compensation
Acceleration. Upon the Executive’s Termination Upon Change of Control, the vesting and exercisability of all then outstanding
stock options and shares of restricted stock (or any other equity award, including, without limitation, stock appreciation rights and
restricted stock units) granted to the Executive under any Company Plans shall be accelerated as to 100% of the shares subject to any
such equity awards granted to the Executive.

 

3.4 Indemnification.
In the event of the Executive’s Termination Upon Change of Control, (a) the Company shall continue to indemnify the Executive against
all claims related to actions arising prior to the termination of the Executive’s employment to the fullest extent permitted by
law, and (b) if the Executive was covered by the Company’s directors’ and officers’ insurance policy, or an equivalent
thereto, (the “D&O Insurance Policy”) immediately prior to the Change of Control, the Company or its Successor
shall continue to provide coverage under a D&O Insurance Policy for not less than twenty-four (24) months following the Executive’s
Termination Upon Change of Control on substantially the same terms of the D&O Insurance Policy in effect immediately prior to the
Change of Control.

 

4. INVOLUNTARY
TERMINATION

 

4.1 Severance
Payment. In the event of the Executive’s Involuntary Termination, the Executive shall be entitled to receive an amount equal
to twelve (12) months of the Executive’s Base Salary, which shall be paid according to the following schedule: (i) a lump sum payment
equal to one-fourth of such amount shall be payable within ten (10) days following the Termination Date, and (ii) one-fourth of such amount
shall be payable within ten (10) days of each of the three-month, six-month and nine-month anniversaries of the Termination Date (and
in each case no interest shall accrue on such amount); provided, however, that if Section 409A of the Code would otherwise apply to such
cash severance payment, it instead shall be paid at such time as permitted by Section 409A of the Code. Notwithstanding the foregoing,
if the Involuntary Termination occurs within the first twelve (12) months following the Effective Date, the amounts paid will instead
equal six (6) months of the Executive’s Base Salary.

 

    2

     

    

 

4.2 COBRA.
The Company will reimburse Executive for the cost of continuation of health coverage for Executive and Executive’s eligible dependents
pursuant to COBRA until the earlier of (i) 12 months following the Termination Date, (ii) the date Executive is eligible for health
coverage for Executive and Executive’s eligible dependents from a new employer or (iii) the date Executive and Executive’s
eligible dependents are no longer eligible for COBRA; provided, however, if, at the time of the Termination Date, the Company determines
that providing the COBRA reimbursement in this paragraph would result in a violation of law or an excise tax to the Company, then the
Company instead will pay a lump sum payment equal to 150% of 12 months of Executive’s estimated COBRA premiums, less applicable
withholdings, within 10 days following the Termination Date.

 

4.3 Equity Compensation
Exercise. Upon the Executive’s Involuntary Termination, the Exercise Period with respect to vested Shares, under the Company
Plans for the purposes of the Executive’s stock options granted under the Company Plans shall be extended so as to expire four (4)
years from the date of Involuntary Termination or the remaining term of the relevant equity award, whichever is the lesser. All unvested
Shares under any such grants or other equity awards shall lapse and no longer be exercisable as of the date of Involuntary Termination.

 

4.4 Indemnification.
In the event of the Executive’s Involuntary Termination, (a) the Company shall continue to indemnify the Executive against all claims
related to actions arising prior to the Termination Date to the fullest extent permitted by law, and (b) if the Executive was covered
by the D&O Insurance Policy immediately prior to the Termination Date, the Company shall continue to provide coverage under a D&O
Insurance Policy for not less than twenty-four (24) months following the Executive’s Involuntary Termination on substantially the
same terms of the D&O Insurance Policy in effect immediately prior to the Termination Date.

 

5.
FEDERAL EXCISE TAX UNDER SECTION 280G

 

5.1 Excise Tax.
If (a) any amounts payable to the Executive under this Agreement or otherwise are characterized as excess parachute payments pursuant
to Section 4999 of the Internal Revenue Code of 1986, as amended (the “Code”), and (b) the Executive thereby
would be subject to any United States federal excise tax due to that characterization, then such amounts will either be (i) delivered
in full, or (ii) delivered to such lesser extent which would result in no portion of such amounts being subject to excise tax pursuant
to Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes
and the excise tax imposed by Code Section 4999, results in Executive’s receipt on an after-tax basis, of the greatest amounts,
notwithstanding that all or some portion of such amounts may be taxable under Code Section 4999. If a reduction in the amounts constituting
“parachute payments” is necessary so that no portion of such amounts are subject to the excise tax under Code Section 4999,
the reduction will occur in the following order: (i) reduction of the cash severance payments, which will occur in reverse chronological
order such that the cash payment owed on the latest date following the occurrence of the event triggering such excise tax will be the
first cash payment to be reduce; (ii) cancellation of accelerated vesting of equity awards which will occur in the reverse order of the
date of grant for such stock awards (i.e., the vesting of the most recently granted stock awards will be reduced first); and (iii) reduction
of continued employee benefits, which will occur in reverse chronological order such that the benefit owed on the latest date following
the occurrence of the event triggering such excise tax will be the first benefit to be reduced. If two or more equity awards are granted
on the same date, each award will be reduced on a pro-rata basis. Notwithstanding the foregoing, no such reduction or elimination shall
apply to any non-qualified deferred compensation amounts (within the meaning of Section 409A of the Code) to the extent such reduction
or elimination would accelerate or defer the timing of such payment in a manner that does not comply with Section 409A of the Code.

 

    3

     

    

 

5.2 Calculation
by Independent Public Accountants. Unless the Company and the Executive otherwise agree in writing, any calculation of the amount
of any excess parachute payments payable by the Executive shall be made in writing by the Company’s independent public accountants
(the “Accountants”) whose conclusion shall be final and binding on the parties. For purposes of making such
calculations, the Accountants may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999
of the Code. The Company and the Executive shall furnish to the Accountants such information and documents as the Accountants may reasonably
request in order to make the required calculations. The Company shall bear all fees and expenses the Accountants may charge in connection
with these services, but the engagement of the Accountants for this purpose shall be pursuant to an agreement between the Executive and
the Accountants.

 

6.
DEFINITIONS

 

6.1 Capitalized
Terms Defined. Capitalized terms used in this Agreement shall have the meanings set forth in this Section 4, unless the context clearly
requires a different meaning.

 

6.2 “Base
Salary” means the greater of (a) if applicable, the monthly salary of the Executive in effect immediately prior to the Change
of Control, or (b) the monthly salary of the Executive in effect immediately prior to the Termination Date.

 

6.3 “Cause”
means:

 

		(a)	the Executive willfully failed
to follow the lawful written directions of the Board of Directors of the Company (the “Board”) or Executive’s
immediate superior; provided that no termination for such Cause shall occur unless the Executive: (i) has been provided with notice,
specifying such willful failure in reasonable detail, of the Company’s intention to terminate the Executive for Cause; and (ii)
has failed to cure or correct such willful failure within thirty (30) days of receiving such notice;

 

		(b)	the Executive engaged in gross
misconduct, or gross incompetence which is materially detrimental to the Company; provided that no termination for such Cause shall occur
unless the Executive: (i) has been provided with notice, specifying such gross misconduct or gross incompetence in reasonable detail,
of the Company’s intention to terminate the Executive for Cause; and (ii) has failed to cure or correct such gross misconduct within
thirty (30) days of receiving such notice;

 

		(c)	the Executive willfully failed
to comply in any material respect with the Employee Invention Assignment & Confidentiality Agreement, the Company’s share dealing
code, the Executive’s non-competition agreement, or any other reasonable policies of the Company where non-compliance would be
materially detrimental to the Company; provided that no termination for such Cause shall occur unless the Executive: (i) has been provided
with notice of the Company’s intention to terminate the Executive for such Cause, and (ii) has failed to cure or correct such willful
failure within thirty (30) days of receiving such notice, provided that such notice and cure period requirements shall not apply in the
event that such non-compliance is of a nature that it is unable to be remedied; or

 

    4

     

    

 

		(d)	the Executive is convicted of
a felony or crime involving moral turpitude (excluding drunk driving unless combined with other aggravating circumstances or offenses)
or fraud that the Company reasonably believes would have a material adverse effect on the Company.

 

6.4 “Change
of Control” means:

 

		(a)	any “person” (as such
term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”))
becomes the “beneficial owner” (as defined in Rule 13d-3 promulgated under the Exchange Act), directly or indirectly, of
securities of the Company representing fifty (50%) percent or more of (i) the outstanding shares of common stock of the Company, or (ii)
the combined voting power of the Company’s outstanding securities;

 

		(b)	the Company is party to a merger
or consolidation, or series of related transactions, which results in the voting securities of the Company outstanding immediately prior
thereto failing to continue to represent (either by remaining outstanding or by being converted into voting securities of the surviving
entity), directly or indirectly, at least fifty (50%) percent of the combined voting power of the voting securities of the Company or
such surviving entity outstanding immediately after such merger or consolidation;

 

		(c)	the sale or disposition of all
or substantially all of the Company’s assets, or consummation of any transaction, or series of related transactions, having similar
effect (other than to a subsidiary of the Company);

 

		(d)	a change in the composition of
the Board within any consecutive two-year period, as a result of which fewer than a majority of the directors are Incumbent Directors.
“Incumbent Directors” shall mean directors who either (i) were directors of the Company as of the effective date of this
Agreement, or (ii) are elected, or nominated for election, to the Board with the affirmative votes of a least a majority of those directors
whose election or nomination was not in connection with an actual or threatened proxy contest related to the election of directors to
the Company; or

 

		(e)	the dissolution or liquidation
of the Company.

 

6.5 “Company”
shall mean IPSIDY INC. and, following a Change of Control, any Successor.

 

6.6 “Company
Plans” shall mean the Company’s 2017 Incentive Stock Plan and any employee equity plan that replaces or supplements
such plan, as well as any grant of stock options, restricted stock, stock appreciation rights, stock award, or stock purchase offer, which
may be made to Executive outside of any such plan.

 

6.7 “Involuntary
Termination” means:

 

		(a)	any termination without Cause
of the employment of the Executive by the Company; or

 

    5

     

    

 

		(b)	any resignation by Executive for
Good Reason where such resignation occurs within one hundred twenty (120) days following the occurrence of such Good Reason.

 

Notwithstanding the foregoing, the term “Involuntary
Termination” shall not include any termination of the employment of the Executive: (1) by the Company for Cause; (2) by the Company
as a result of the Permanent Disability of the Executive; (3) as a result of the death of the Executive; (4) as a result of the voluntary
termination of employment by the Executive for any reason other than Good Reason (5) that would qualify as a Termination Upon Change of
Control hereunder.

 

6.8 “Good
Reason” means the occurrence of any of the following conditions, without the Executive’s written consent:

 

		(a)	Any act, set of facts or omissions
with respect to the Executive that would, as a matter of applicable law, constitute a constructive termination of the Executive.

 

		(b)	The assignment to the Executive
of a title, position, responsibilities or duties that is not a “Substantive Functional Equivalent” to the title, position,
responsibilities or duties which the Executive had immediately prior to such assignment (including, as relevant, immediately prior to
the public announcement of the Change of Control).

 

		(c)	A material reduction in the Executive’s
Base Salary or, if applicable, target bonus opportunity (subject to applicable performance requirements with respect to the actual amount
of bonus compensation earned similar to the applicable performance requirements currently in effect), and in the event of a Change of
Control, as compared to Executive’s Base Salary and target bonus opportunity in effect immediately prior to the public announcement
of the Change of Control; provided, however, that this clause (c) shall not apply in the event of a reduction in the Executive’s
Base Salary or, if applicable, target bonus opportunity as part of a Company-wide or executive team-wide cost-cutting measure or Company-wide
or executive team-wide cutback as a result of overall Company performance.

 

		(d)	The failure of the Company (i)
to continue to provide the Executive an opportunity to participate in any benefit or compensation plans provided to employees who hold
positions with the Company comparable to the Executive’s position, (ii) to provide the Executive all other fringe benefits (or
the equivalent) in effect for the benefit of any employee group which includes any employee who hold a position with the Company comparable
to the Executive’s position, where in the event of a Change of Control, such comparison shall be made relative to the time immediately
prior to the public announcement of such Change of Control); or (iii) continue to provide director’s and officers’ insurance.

 

		(e)	A material breach of this Agreement
by the Company, including, in the event of a Change of Control, failure of the Company to obtain the consent of a Successor to perform
all of the obligations of the Company under this Agreement.

 

The Executive must first give the Company an opportunity
to cure any of the foregoing within thirty (30) days following delivery to the Company of a written explanation specifying the specific
basis for Executive’s belief that Executive is entitled to terminate employment for Good Reason, and Executive terminates employment
with the Company not later than (30) days following the Company’s failure to cure.

 

    6

     

    

 

6.9 “Permanent
Disability” means that:

 

		(a)	the Executive has been incapacitated
by bodily injury, illness or disease so as to be prevented thereby from engaging in the performance of the Executive’s duties;

 

		(b)	such total incapacity shall have
continued for a period of six consecutive months; and

 

		(c)	such incapacity will, in the opinion
of a qualified physician, be permanent and continuous during the remainder of the Executive’s life.

 

6.10 “Substantive
Functional Equivalent” means that the Executive’s position must:

 

		(a)	be in a substantive area of the
Executive’s competence (e.g., finance or executive management) and not materially different from the position occupied immediately
prior;

 

		(b)	allow the Executive to serve in
a role and perform duties functionally equivalent to those performed immediately prior; and

 

		(c)	not otherwise constitute a material,
adverse change in authority, title, status, responsibilities or duties from those of the Executive immediately prior, causing the Executive
to be of materially lesser rank or responsibility, including requiring the Executive to report to a person other than the Board.

 

6.11 “Successor”
means any successor in interest to, or assignee of, substantially all of the business and assets of the Company.

 

6.12 “Termination
Date” means the date of the termination of the Executive’s employment with the Company.

 

6.13 “Termination
Upon Change of Control” means:

 

		(a)	any termination of the employment
of the Executive by the Company without Cause during the period commencing on or after the date that the Company first publicly announces
a definitive agreement that results in a Change of Control (even though still subject to approval by the Company’s stockholders
and other conditions and contingencies, but provided that the Change of Control actually occurs) and ending on the date which is twelve
(12) months following the Change of Control; or

 

		(b)	any resignation by Executive for
Good Reason where (i) such Good Reason occurs during the period commencing on or after the date that the Company first publicly announces
a definitive agreement that results in a Change of Control (even though still subject to approval by the Company’s stockholders
and other conditions and contingencies, but provided that the Change of Control actually occurs) and ending on the date which is twelve
(12) months following the Change of Control, and (ii) such resignation occurs at or after such Change in Control and in any event within
twelve (12) months following the expiration of any Company cure period.

 

    7

     

    

 

Notwithstanding the foregoing, the term “Termination
Upon Change of Control” shall not include any termination of the employment of the Executive: (1) by the Company for Cause; (2)
by the Company as a result of the Permanent Disability of the Executive; (3) as a result of the death of the Executive; or (4) as
a result of the voluntary termination of employment by the Executive for any reason other than Good Reason.

 

7.
EXCLUSIVE REMEDY

 

7.1 No Other
Benefits Payable. The Executive shall be entitled to no other termination, severance or change of control compensation, benefits,
or other payments from the Company as a result of any termination with respect to which the payments and benefits described in Section
2 have been provided to the Executive, except as expressly set forth in this Agreement.

 

7.2 No Limitation
of Regular Benefit Plans. Except as may be provided elsewhere in this Agreement, this Agreement is not intended to and shall not affect,
limit or terminate any plans, programs or arrangements of the Company that are regularly made available to a significant number of employees
or officers of the Company, including, without limitation, the Company’s stock option plans.

 

7.3 Release
of Claims. The payment of the benefits described in Sections 3 and 4 of this Agreement is conditioned upon the delivery by the Executive
to the Company of a signed and effective general release of claims as provided by the Company in the form attached hereto as Exhibit 1;
provided, however, that the Executive shall not be required to release any rights the Executive may have to be indemnified by the Company
or as otherwise provided under this Agreement.

 

7.4 Noncumulation
of Benefits. The Executive may not cumulate cash severance payments, stock option vesting and exercisability and restricted stock
vesting under this Agreement, any other written agreement with the Company and/or another plan or policy of the Company. If the Executive
has any other binding written agreement with the Company which provides that, upon a Change of Control or Termination Upon a Change of
Control or Involuntary Termination, the Executive shall receive termination, severance or similar benefits, then no benefits shall be
received by Executive under this Agreement unless, prior to payment or receipt of benefits under this Agreement, the Executive waives
Executive’s rights to all such other benefits, in which case this Agreement shall supersede any such written agreement with respect
to such other benefits.

 

8.
ARBITRATION

 

8.1 Disputes
Subject to Arbitration. Any claim, dispute or controversy arising out of this Agreement (other than claims relating to misuse or misappropriation
of the intellectual property of the Company), the interpretation, validity or enforceability of this Agreement or the alleged breach thereof
shall be submitted by the parties to binding arbitration by a sole arbitrator under the rules of the American Arbitration Association;
provided, however, that (a) the arbitrator shall have no authority to make any ruling or judgment that would confer any rights with respect
to the trade secrets, confidential and proprietary information or other intellectual property of the Company upon the Executive or any
third party; and (b) this arbitration provision shall not preclude the Company from seeking legal and equitable relief from any court
having jurisdiction with respect to any disputes or claims relating to or arising out of the misuse or misappropriation of the Company’s
intellectual property. Judgment may be entered on the award of the arbitrator in any court having jurisdiction.

 

8.2 Costs of
Arbitration. All costs of arbitration, including reasonable attorney’s fees of the Executive, will be borne by the Company,
except that if the Executive initiates arbitration and the arbitrator finds the Executive’s claims to be frivolous the Executive
shall be responsible for his own costs and attorneys’ fees.

 

    8

     

    

 

8.3 Site of
Arbitration. The site of the arbitration proceeding shall be in Santa Clara County, California.

 

9.
NOTICES

 

For purposes of this Agreement, notices and all
other communications provided for in the Agreement shall be in writing and shall be deemed to have been duly given when delivered or five
(5) business days after being mailed, return receipt requested, as follows: (a) if to the Company, attention: General Counsel, at the
Company’s offices at 670 Long Beach Boulevard, Long Beach, New York 11561 USA or legal@ipsidy.com and, (b) if to the Executive,
at the address indicated below or such other address specified by the Executive in writing to the Company. Either party may provide the
other with notices of change of address, which shall be effective upon receipt.

 

12. MISCELLANEOUS PROVISIONS

 

12.1 Heirs and Representatives
of the Executive; Successors and Assigns of the Company. This Agreement shall be binding upon and shall inure to the benefit of and
be enforceable by the Executive’s personal and legal representatives, executors, administrators, successors, heirs, distributees,
devises and legatees. This Agreement shall be binding upon and inure to the benefit of and be enforceable by the successors and assigns
of the Company.

 

12.2 Amendment and Waiver.
No provision of this Agreement shall be modified, amended, waived or discharged unless the modification, amendment, waiver or discharge
is agreed to in writing, specifying such modification, amendment, waiver or discharge, and signed by the Executive and by an authorized
officer of the Company (other than the Executive). No waiver by either party of any breach of, or of compliance with, any condition or
provision of this Agreement by the other party shall be considered a waiver of any other condition or provision or of the same condition
or provision at another time.

 

12.3 Withholding Taxes. All payments made
under this Agreement shall be subject to deduction of all federal, state, local and other taxes required to be withheld by applicable
law.

 

12.4 Severability. The invalidity or unenforceability
of any provision or provisions of this Agreement shall not affect the validity or enforceability of any other provision hereof, which
shall remain in full force and effect.

 

12.5 Choice of Law. The validity, interpretation,
construction and performance of this Agreement shall be governed by the laws of the State of California, without regard to where the Executive
has his residence or principal office or where he performs his duties hereunder.

 

12.6 No Duty to Mitigate. The Executive
is not required to seek alternative employment following termination, and payments called for under this Agreement will not be reduced
by earnings from any other source.

 

    9

     

    

 

12.7. Section 409A of the Code. The intent
of the parties is that payments and benefits under this Agreement comply with Section 409A of the Code and the Treasury Regulations and
guidance promulgated thereunder (“Section 409A”), to the extent subject thereto, and accordingly, to the maximum extent
permitted, this letter shall be interpreted and administered to be in compliance therewith. Notwithstanding anything contained herein
to the contrary, Executive shall not be considered to have terminated employment with the Company for purposes of any provision in this
Agreement providing for the payment of any amounts or benefits subject to Section 409A upon or following a termination of employment until
Executive would be considered to have incurred a “separation from service” from the Company within the meaning of Section
409A and this Agreement shall be interpreted consistently therewith. Without limiting the foregoing, and notwithstanding anything to the
contrary contained herein,to the extent (a) any payments or benefits to which Executive becomes entitled under this Agreement, or under
any agreement or plan referenced herein, in connection with Executive’s termination of employment with the Company constitute deferred
compensation subject to Section 409A of the Code and (b) Executive is deemed at the time of such termination of employment to be a “specified
employee” under Section 409A of the Code, then such payments shall not be made or commence until the earliest of (i) the expiration
of the six (6)-month period measured from the date of Executive’s “separation from service” (as such term is at the
time defined in Treasury Regulations under Section 409A of the Code) from the Company; or (ii) the date of Executive’s death following
such separation from service; provided, however, that such deferral shall only be effected to the extent required to avoid adverse tax
treatment to Executive, including (without limitation) the additional twenty percent (20%) tax for which Executive would otherwise be
liable under Section 409A(a)(1)(B) of the Code in the absence of such deferral. Upon the expiration of the applicable deferral period,
any payments which would have otherwise been made during that period (whether in a single sum or in installments) in the absence of this
paragraph shall be paid to Executive or Executive’s beneficiary in one lump sum (without interest). Any termination of Executive’s
employment is intended to constitute a “separation from service” as such term is defined in Treasury Regulation Section 1.409A-1.
It is intended that each installment of the payments provided hereunder constitute separate and distinct “payments” for purposes
of Section 1.409Aof the Code. It is further intended that payments hereunder satisfy, to the greatest extent possible, the exemption from
the application of Code Section 409A (and any state law of similar effect) provided under Treasury Regulation Section 1.409A-1(b)(4) (as
a “short-term deferral”). The Company makes no representation that any or all of the payments described or referenced in this
letter will be exempt from or comply with Section 409A and makes no undertaking to preclude Section 409A from applying to any such payment,
and Company’s only obligation is to comply with its obligations set forth herein.

 

12.8 Entire Agreement. This Agreement represents
the entire agreement and understanding between the parties as to the subject matter herein (whether oral or written and whether express
or implied). The Executive hereby acknowledges, represents and warrants that he has been individually represented by counsel in negotiating
and signing this agreement.

 

[SIGNATURE PAGE FOLLOWS]

 

    10

     

    

  

In Witness
Whereof, each of the parties has executed this Agreement, in the case of the Company, by its duly authorized officer, as of the
day and year first above written.

 

	 	Executive
	 	 
	 	/s/ Tom Thimot
	 	Thomas Thimot
	 	 
	 	333 Johnson Ave, 
	 	Los Gatos, CA 95030
	 	 
	 	Ipsidy Inc.
	 	 	 
	 	By:	/s/ Phillip Kumnick
	 	 	Phillip L. Kumnick, CEO

 

     

     

    

  

EXHIBIT 1

 

RELEASE OF CLAIMS

 

This General Release of all
Claims (this “Release”) is entered into on [●], by and between Ipsidy Inc., a Delaware corporation (the “Company”),
and Thomas Thimot (the “Executive”).

 

In accordance with Section
7.3 of the Executive Retention Agreement by and between the Company and the Executive, effective __________, 2021 (the “Retention
Agreement”), in consideration of the payments and benefits to which the Executive is entitled pursuant to the Retention Agreement
subject to the execution and non-revocation of this Release, the Executive agrees as follows:

 

		●	General Release and Waiver of Claims.

 

		o	Release. The Executive and each of the Executive’s
respective heirs, executors, administrators, representatives, agents, successors and assigns (collectively, the “Releasors”)
hereby irrevocably and unconditionally release and forever discharge the Company and each of its subsidiaries and affiliates and each
of their respective officers, employees, directors, managers, shareholders and agents (“Releasees”) from any and all
claims, actions, causes of action, rights, judgments, obligations, damages, demands, accountings or liabilities of whatever kind or character
(collectively, “Claims”), including, without limitation, any Claims under any federal, state, local or foreign law,
that the Releasors may have or in the future may possess, arising out (i) of the Executive’s employment relationship with and service
as an employee, officer, manager or director of the Company, and the termination of such relationship or service and (ii) any event,
condition, circumstance or obligation that occurred, existed or arose on or prior to the date hereof; provided, however, that
notwithstanding anything else herein to the contrary, this Release shall not affect: the obligations of the Company to pay the amounts
due and owing to Executive on the Termination Date or other obligations that, in each case, by their terms, are to be performed after
the date hereof by the Company; any indemnification or similar rights the Executive has as a current or former officer, manager or director
of the Company, including, without limitation, any and all rights thereto referenced in the Company’s governance documents or any
rights with respect to “directors’ and officers’” insurance policies; and the Executive’s right to reimbursement
of business expenses.

 

		o	Specific Release of ADEA Claims. The Releasors hereby
unconditionally release and forever discharge the Releasees from any and all Claims that the Releasors may have as of the date the Executive
signs this Release arising under the Federal Age Discrimination in Employment Act of 1967, as amended, and the applicable rules and regulations
promulgated thereunder (“ADEA”). By signing this Release, the Executive hereby acknowledges and confirms the following:
(i) the Executive was advised by the Company in connection with his termination to consult with an attorney of his choice prior
to signing this Release and to have such attorney explain to the Executive the terms of this Release, including, without limitation,
the terms relating to the Executive’s release of claims arising under ADEA, and the Executive has in fact consulted with an attorney;
(ii) the Executive was given a period of not fewer than twenty-one (21) calendar days to consider the terms of this Release and
to consult with an attorney of his choosing with respect thereto; and (iii) the Executive knowingly and voluntarily accepts the
terms of this Release. The Executive also understands that he has seven (7) calendar days following the date on which he signs this
Release within which to revoke the release contained in this paragraph, by providing the Company a written notice of his revocation of
the release and waiver contained in this paragraph.

 

     

     

    

 

		o	Release of All Claims. The Executive acknowledges, understands
and agrees that he may later discover Claims or facts in addition to or different from those which he now knows or believes to be true
with respect to the subject matters of this Release, but that it is nevertheless his intention by signing this Release to fully, finally
and forever release any and all Claims whether now known or unknown, suspected or unsuspected, which now exist, may exist, or previously
have existed as set forth herein.

 

		o	California Civil Code Section 1542 Waiver. The Executive
has read the provisions of California Civil Code Section 1542 and has consulted his own counsel regarding that section. The Executive
waives any and all rights under California Civil Code Section 1542, which states:

 

A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR
OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM
OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.

 

		o	Executive agrees and acknowledges that the released claims extend
to and include unknown and unsuspected claims. In furtherance of the Executive’s intent, the release in this Release shall remain
in full and complete effect notwithstanding the discovery or existence of any additional, contrary, or different facts.

 

		o	No Assignment. The Executive represents and warrants
that he has not assigned any of the Claims being released under this Release.

 

●
Proceedings. The Executive has not filed, and agrees not to initiate or cause to be initiated on his behalf, any complaint,
charge, claim or proceeding against the Releasees before any local, state or federal agency, court or other body, other than in respect
of any matter described in the proviso to Section 1(a) of this Release (each, individually, a “Proceeding”), and agrees
not to participate voluntarily in any Proceeding. The Executive waives any right he may have to benefit in any manner from any relief
(whether monetary or otherwise) arising out of any Proceeding.

 

●
Remedies. The Executive understands that by entering into this Release he will be limiting the availability of certain remedies
that he may have against the Company and limiting also his ability to pursue certain claims against the Company.

 

●
Severability Clause. In the event any provision or part of this Release is found to be invalid or unenforceable, only that
particular provision or part so found, and not the entire Release, will be inoperative.

 

●
Non-admission. Nothing contained in this Release will be deemed or construed as an admission of wrongdoing or liability
on the part of the Company.

 

●
Governing Law. All matters affecting this Release, including the validity thereof, are to be governed by, and interpreted
and construed in accordance with, the laws of the State of California applicable to contracts executed in and to be performed in that
State.

 

●
Capitalized Terms. Capitalized terms used but not defined herein have the meanings ascribed to them in the Retention Agreement.

 

     

     

    

 

THE EXECUTIVE ACKNOWLEDGES THAT HE HAS READ
THIS RELEASE AND THAT HE FULLY KNOWS, UNDERSTANDS AND APPRECIATES ITS CONTENTS, AND THAT HE HEREBY EXECUTES THE SAME AND MAKES THIS AGREEMENT
AND THE RELEASE AND AGREEMENTS PROVIDED FOR HEREIN VOLUNTARILY AND OF HIS OWN FREE WILL.

 

IN WITNESS WHEREOF, the Executive
has executed this Release on the date first set forth below.

 

	EXECUTIVE:	 
	 	 
	 	 
	THOMAS THIMOT	 
	 	 
	ACKNOWLEDGED AND AGREED	 
	 	 
	IPSIDY INC.	 
	 	 
	By:	                                	 
	Its:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]